Correspondence 0001193125-24-138935 from Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc.
Date: May 15, 2024 · CIK: 0001707502 · Accession: 0001193125-24-138935
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-277871
Letter
Re: Solid Biosciences Inc.
May 15, 2024
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Jimmy McNamara
Registration Statement on Form S-3
Filed March 13, 2024
File No. 333-277871
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-277871), so that it may become effective at 9:30 a.m., Eastern time, on May 17, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
By:
Show Raw Text
CORRESP 1 filename1.htm CORRESP May 15, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Jimmy McNamara Re: Solid Biosciences Inc. Registration Statement on Form S-3 Filed March 13, 2024 File No. 333-277871 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-277871), so that it may become effective at 9:30 a.m., Eastern time, on May 17, 2024, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, By: /s/ Alexander Cumbo Alexander Cumbo Chief Executive Officer